Recent Posts
- ACTIVIST SHAREHOLDER FILES SCHEDULE 13D IN EQUUS TOTAL RETURN, INC.
- CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World’s First Bispecific Antibody for Passive Immunization Against Rabies
- The Pool Factory Strengthens Its Position as a Leading U.S. Provider of Above Ground Pools and Outdoor Living Products
- Sui News: Cumberland, Fluid, and SwissBorg Join Institutional Coalition on Hashi Ahead of July Global Testnet
- X-tosis Receives Grant from The Michael J. Fox Foundation to Advance Novel Parkinson’s Disease Therapy

